Dr. Tang invited to exhibit latest research on VR-based myopia therapy at TechConnect World Innovation Conference & Expo

We are pleased to announce that our esteemed Principle Investigator, Dr. YM Tang, exhibited our latest research at the TechConnect World Innovation Conference & Expo. The event was held from 19-21 June, 2023 at Washington, DC, and was renowned for connecting top applied research and early-stage innovations from universities, labs, and startups with industry end-users and prospectors.

The conference comprised several programs, including the annual SBIR/STTR Innovation Conference, AI TechConnect, the TechConnect Technical Program, and the Nanotech Conference Series. The exhibition was the largest and longest-running nanotechnology event in the world, offering a platform for researchers and innovators to showcase their latest findings to a global audience.

Dr. Tang’s exhibit focused on our latest research project, titled “Accommodation Myopia Therapy Training Using Virtual Reality (VR) Head Mounted Device for Adolescents and Children.” The project, which had garnered significant attention in the scientific community, aimed at developing a novel VR-based training program for the treatment of myopia in children and adolescents.

The innovative therapy leveraged the immersive capabilities of VR technology to simulate real-world scenarios that require the eyes to focus and work in tandem, thus helping to improve visual acuity and reduce the onset of myopia. The program had shown great promise in early-stage trials, and Dr. Tang was excited to share our latest findings with the wider scientific community at the TechConnect World Innovation Conference & Expo.

Over the years, TechConnect had published over 10,000 technical papers, connected over 20,000 innovations with industry partners, provided prospecting to most all Fortune 500 technology companies, and supported most every U.S. Science and Technology agency, including the National Nanotechnology Initiative since its inception. We were honored to have been part of this prestigious event and to have had the opportunity to exhibit our research to fellow innovators, industry leaders, and potential partners.